摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(allyloxy)-N,N,1,2-dimethyl-1H-benzimidazol-6-carboxamide | 1034023-24-9

中文名称
——
中文别名
——
英文名称
4-(allyloxy)-N,N,1,2-dimethyl-1H-benzimidazol-6-carboxamide
英文别名
——
4-(allyloxy)-N,N,1,2-dimethyl-1H-benzimidazol-6-carboxamide化学式
CAS
1034023-24-9
化学式
C15H19N3O2
mdl
——
分子量
273.335
InChiKey
ZDWRINNUSXZGMS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.15
  • 重原子数:
    20.0
  • 可旋转键数:
    4.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    47.36
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(allyloxy)-N,N,1,2-dimethyl-1H-benzimidazol-6-carboxamide 反应 4.0h, 以81%的产率得到5-allyl-4-hydroxy-N,N,1,2-tetramethyl-1H-benzimidazole-6-carboxamide
    参考文献:
    名称:
    Synthesis and pharmacological evaluation of potential metabolites of the potassium-competitive acid blocker BYK405879
    摘要:
    Four potential metabolites of the potassium-competitive acid blocker BYK 405879 (1) were synthesized which might be formed in vivo by enzymatic oxidation of the pyran moiety or the methyl groups attached to the (hetero) aromatic system. In all cases, the oxidation of the parent compound 1 was accompanied by a significant loss of pharmacological activity and by a decrease in lipophilicity. The target compounds 6, 14, 20, and 21 constitute valuable tool substances for the investigation of the metabolic fate of BYK 405879 (1). (c) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2009.04.070
  • 作为产物:
    描述:
    7-羟基-N,N,2,3-四甲基苯并咪唑-5-甲酰胺3-溴丙烯potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以78%的产率得到4-(allyloxy)-N,N,1,2-dimethyl-1H-benzimidazol-6-carboxamide
    参考文献:
    名称:
    Synthesis and pharmacological evaluation of potential metabolites of the potassium-competitive acid blocker BYK405879
    摘要:
    Four potential metabolites of the potassium-competitive acid blocker BYK 405879 (1) were synthesized which might be formed in vivo by enzymatic oxidation of the pyran moiety or the methyl groups attached to the (hetero) aromatic system. In all cases, the oxidation of the parent compound 1 was accompanied by a significant loss of pharmacological activity and by a decrease in lipophilicity. The target compounds 6, 14, 20, and 21 constitute valuable tool substances for the investigation of the metabolic fate of BYK 405879 (1). (c) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2009.04.070
点击查看最新优质反应信息

文献信息

  • WO2008/71765
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多